Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(2):e31674.
doi: 10.1371/journal.pone.0031674. Epub 2012 Feb 16.

HIV-1 subtype D infections among Caucasians from Northwestern Poland--phylogenetic and clinical analysis

Affiliations

HIV-1 subtype D infections among Caucasians from Northwestern Poland--phylogenetic and clinical analysis

Miłosz Parczewski et al. PLoS One. 2012.

Abstract

Background: HIV-1 subtype D infections, which are associated with a faster rate of progression and lymphocyte CD4 decline, cognitive deficit and higher mortality, have rarely been found in native Europeans. In Northwestern Poland, however, infections with this subtype had been identified. This study aimed to analyze the sequence and clinical data for patients with subtype D using molecular phylogeography and identify transmission clusters and ancestry, as well as drug resistance, baseline HIV tropism and antiretroviral treatment efficacy.

Methods: Phylogenetic analyses of local HIV-1 subtype D sequences were performed, with time to the most recent common ancestor inferred using bayesian modeling. Sequence and drug resistance data were linked with the clinical and epidemiological information.

Results: Subtype D was found in 24 non-immigrant Caucasian, heterosexually infected patients (75% of females, median age at diagnosis of 49.5 years; IQR: 29-56 years). Partial pol sequences clustered monophyletically with the clades of Ugandan origin and no evidence of transmission from other European countries was found. Time to the most common recent ancestor was 1989.24 (95% HPD: 1968.83-1994.46). Baseline drug resistance to nucleoside reverse transcriptase inhibitors was observed in 54.5% of cases (mutations: M41L, K103N, T215S/D) with evidence of clustering, no baseline integrase or protease resistance and infrequent non-R5 tropism (13.6%). Virologic failure was observed in 60% of cases and was associated with poor adherence (p<0.001) and subsequent development of drug resistance (p = 0.008, OR: 20 (95%CI: 1.7-290).

Conclusions: Local subtype D represented an independently transmitted network with probably single index case, high frequency of primary drug resistance and evidence of transmission clusters.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Relationships between the subtype D sequences inferred using maximum likelihood phylogeny (GenBank deposited pol sequences).
Country-specific sequences are marked with the same color: red – Poland, blue – Uganda, green – Tanzania, yellow – Europe (except Poland), brown – Cameroon, magenta - Senegal, cyan- Sudan, dark green – other African countries, violet – South America, grey – Asia, orange – North America.
Figure 2
Figure 2. Phylogenetic trees of the subtype D sequences from Northwestern Poland.
Figure a - maximum likelihood tree with bootstrap values for 1000 replicates drawn at the branches. Figure b – time scaled Bayesian MCMC tree. On the tree branches estimated time to the most recent common ancestor (tMRCA) and posterior probabilities expressed as percentage are shown. For both figures clustered sequences are marked in red and four identified clusters indicated as blue boxes and numbered are drawn on the right. Drug resistance mutations are marked at the tip nodes after the sequence identifier. *source patient for the transmission of the drug resistance within the cluster.
Figure 3
Figure 3. Bayesian skyline plot for estimation of the number of subtype D HIV-1 cases in the local population.
95% CI are marked in blue. Y-axis: predicted number of cases (log scale), X-axis: timescale (years).
Figure 4
Figure 4. Frequency of baseline drug resistance mutations among treatment-naive patients.
Figure 5
Figure 5. Frequency of secondary drug resistance mutations in patients failing antiretroviral therapy.

Similar articles

Cited by

References

    1. Drummond AJ, Ho SY, Phillips MJ, Rambaut A. Relaxed phylogenetics and dating with confidence. PLoS biology. 2006;4:e88. - PMC - PubMed
    1. Lewis F, Hughes GJ, Rambaut A, Pozniak A, Leigh Brown AJ. Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS medicine. 2008;5:e50. - PMC - PubMed
    1. Paraskevis D, Magiorkinis E, Magiorkinis G, Sypsa V, Paparizos V, et al. Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin. The Journal of infectious diseases. 2007;196:1167–1176. - PubMed
    1. Geretti AM. HIV-1 subtypes: epidemiology and significance for HIV management. Current opinion in infectious diseases. 2006;19:1–7. - PubMed
    1. Buonaguro L, Petrizzo A, Tagliamonte M, Vitone F, Re MC, et al. Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy. Infectious agents and cancer. 2008;3:13. - PMC - PubMed

Publication types

Substances

Associated data